does blue cross blue shield cover glp-1 Excellus clarifies coverage ahead of 2026 formulary changes Why we are changing coverage

Early intervention helps prevent the condition from becoming chronic, allowing you to return to your daily routine quickly

FAD, Flavin adenine dinucleotide

Its ongoing use in laboratory literature reflects research interest only and does not indicate therapeutic, cosmetic, or clinical benefit

Complete approach: BPC-157: 500mcg daily split between local injection near injury and systemic TB-500: Loading phase 5mg twice weekly for 6 weeks, then 2.5mg weekly maintenance GHK-Cu: 3mg daily for collagen synthesis and tissue remodeling Optional: Low-dose growth hormone peptides to support healing Implementation schedule: Morning: BPC-157 250mcg injected near patellar tendon Evening: BPC-157 250mcg systemic (abdomen) + GHK-Cu 3mg Monday/Thursday: TB-500 5mg (weeks 1-6), then once weekly (weeks 7-12) Duration: 8-12 weeks acute healing phase, possible maintenance at lower doses if needed